← Open Payments lookup

MEGHAN MILLER: Open Payments

NPI 1225271539 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$851 in 47 payments from 15 companies in 2025. Trend: 2023 $1,160 · 2024 $1,361 · 2025 $851

Food & beverage: $851
CompanyPaymentsAmount
Novo Nordisk Inc15$252
Astellas Pharma US Inc6$133
Vanda Pharmaceuticals Inc.3$77
PFIZER INC.3$54
Otsuka America Pharmaceutical, Inc.2$46
Boehringer Ingelheim Pharmaceuticals, Inc.3$46
AstraZeneca Pharmaceuticals LP3$43
Axsome Therapeutics, Inc.2$37
ABBVIE INC.2$37
Lilly USA, LLC2$30

Products named: Veozah, Ozempic, Wegovy, FANAPT, JARDIANCE, REXULTI, Auvelity, QULIPTA.

Industry payments across IN — which companies pay providers there.